Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amerant Bancorp Inc.AMTB · Entity 4887 | Director | June 02, 2026 | June 04, 2026 |
| AramarkARMK · Entity 3359 | Director | August 29, 2019 | September 04, 2019 |
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | Director | May 05, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amerant Bancorp Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,885 |
Reported balance
After 2026-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 2,885 · Balance 2,885 F1: Each restricted stock unit ("RSU") is the economic equivalent of one share of Class A Common Stock. F2: On June 2, 2026, the reporting person was granted 2,885 RSUs. Such RSU award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2027 or through the first anniversary of the date of grant. Each RSU represents a right to receive one share of Class A Common Stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") is the economic equivalent of one share of Class A Common Stock.
F2: On June 2, 2026, the reporting person was granted 2,885 RSUs. Such RSU award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2027 or through the first anniversary of the date of grant. Each RSU represents a right to receive one share of Class A Common Stock upon vesting.
Aramark
Report date August 29, 2019 · Filed September 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,361.719 |
Reported balance
After 2019-08-29 transaction · row 1
1 source rowRow 1 · 2019-08-29 · Grant · Acquired 13.371 · Balance 13,361.719 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
BAXTER INTERNATIONAL INC
Report date May 05, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 42,386 |
Reported balance
After 2026-05-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-05 · Grant · Acquired 12,836 · Balance 42,386 F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2: Total includes the automatic reinvestment of dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant.
F2: Total includes the automatic reinvestment of dividends.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CARDINAL HEALTH INC
Report date August 31, 2018 · Filed September 05, 2018
Section 16 reporting ended · disclosed 2018-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 30,725 |
Reported balance
After 2018-08-31 transaction · row 1
1 source rowRow 1 · 2018-08-31 · Tax withholding · Disposed 2,719 · Balance 30,725 F1: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,059 restricted share units. F2: Reflects closing price on prior business day. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,059 restricted share units.
F2: Reflects closing price on prior business day.
SPLUNK INC
Report date March 18, 2024 · Filed March 21, 2024
Section 16 reporting ended · disclosed 2024-03-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-03-18 · Disposition to issuer · Disposed 36,566 · Balance 695 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated September 20, 2023, by and among the Issuer, Cisco Systems, Inc., a Delaware corporation ("Parent"), and Spirit Merger Corp., a Delaware corporation and a direct wholly owned subsidiary of Parent ("Merger Sub"), on March 18, 2024 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $157.00 in cash per share without interest, subject to applicable withholding taxes, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Row 2 · 2024-03-18 · Disposition to issuer · Disposed 695 · Balance 0 F2: Pursuant to the Merger Agreement, each Vested Company RSU outstanding and that has not yet been settled as of immediately prior to the effective time of the Merger (the "Effective Time") was terminated and converted into the right to receive an amount in cash, without interest, subject to applicable withholding taxes, determined by multiplying (x) the number of shares of Issuer common stock issuable upon settlement of such Vested Company RSU by (y) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated September 20, 2023, by and among the Issuer, Cisco Systems, Inc., a Delaware corporation ("Parent"), and Spirit Merger Corp., a Delaware corporation and a direct wholly owned subsidiary of Parent ("Merger Sub"), on March 18, 2024 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $157.00 in cash per share without interest, subject to applicable withholding taxes, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, each Vested Company RSU outstanding and that has not yet been settled as of immediately prior to the effective time of the Merger (the "Effective Time") was terminated and converted into the right to receive an amount in cash, without interest, subject to applicable withholding taxes, determined by multiplying (x) the number of shares of Issuer common stock issuable upon settlement of such Vested Company RSU by (y) the Merger Consideration.
VIRTUSA CORP
Report date February 11, 2021 · Filed February 11, 2021
Section 16 reporting ended · disclosed 2021-02-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-02-11 transaction · row 1
1 source rowRow 1 · 2021-02-11 · Disposition to issuer · Disposed 4,773 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of September 9, 2020 (the "Merger Agreement"), by and among Austin HoldCo Inc., Austin BidCo Inc. ("Sub"), and the Issuer, pursuant to which Sub merged with and into the Issuer (the "Merger") effective as of February 11, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding share of common stock of the Issuer and each unvested restricted stock unit held by the reporting person was cancelled and converted into the right to receive $51.35 in cash without interest and net of any withholding of taxes thereon. F2: Includes 4,773 unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of September 9, 2020 (the "Merger Agreement"), by and among Austin HoldCo Inc., Austin BidCo Inc. ("Sub"), and the Issuer, pursuant to which Sub merged with and into the Issuer (the "Merger") effective as of February 11, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding share of common stock of the Issuer and each unvested restricted stock unit held by the reporting person was cancelled and converted into the right to receive $51.35 in cash without interest and net of any withholding of taxes thereon.
F2: Includes 4,773 unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 4, 2026 21:47 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | GrantRestricted Stock Units · Derivative | 2,885 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001204081-26-000002 · wk-form4_1780609653.xml · derivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,885 Underlying: Class A Common Stock · 2,885 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") is the economic equivalent of one share of Class A Common Stock. F2 · derivative.exercise_date: On June 2, 2026, the reporting person was granted 2,885 RSUs. Such RSU award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2027 or through the first anniversary of the date of grant. Each RSU represents a right to receive one share of Class A Common Stock upon vesting. F2 · derivative.expiration_date: On June 2, 2026, the reporting person was granted 2,885 RSUs. Such RSU award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2027 or through the first anniversary of the date of grant. Each RSU represents a right to receive one share of Class A Common Stock upon vesting. Read SEC document |
| May 05, 2026 Filed May 7, 2026 20:19 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 12,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-032176 · wk-form4_1778185179.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,386 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:25 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 7,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-008899 · form4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,137 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| May 07, 2024 Filed May 9, 2024 20:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 5,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009781 · form4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,367 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. F2 · balance_after: Total includes the automatic reinvestment of dividends. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:00 UTC | SPLUNK INC SPLK · Entity 92815 | Disposition to issuerCommon Stock | 695 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-008790 · form4-03202024_080307.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, each Vested Company RSU outstanding and that has not yet been settled as of immediately prior to the effective time of the Merger (the "Effective Time") was terminated and converted into the right to receive an amount in cash, without interest, subject to applicable withholding taxes, determined by multiplying (x) the number of shares of Issuer common stock issuable upon settlement of such Vested Company RSU by (y) the Merger Consideration. Read SEC document |
| March 18, 2024 Filed Mar 21, 2024 00:00 UTC | SPLUNK INC SPLK · Entity 92815 | Disposition to issuerCommon Stock | 36,566 | $157.00 | $5,740,862.00 |
DisclosureSEC source: 0001415889-24-008790 · form4-03202024_080307.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 695 F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated September 20, 2023, by and among the Issuer, Cisco Systems, Inc., a Delaware corporation ("Parent"), and Spirit Merger Corp., a Delaware corporation and a direct wholly owned subsidiary of Parent ("Merger Sub"), on March 18, 2024 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, these shares were cancelled and converted into the right to receive $157.00 in cash per share without interest, subject to applicable withholding taxes, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 20:20 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 2,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039379 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,261 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2023, December 10, 2023, March 10, 2024 and June 10, 2024 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 02, 2023 Filed May 4, 2023 20:33 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 4,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010208 · form4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,984 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 20:28 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 2,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040234 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,484 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2022, December 10, 2022, March 10, 2023 and June 10, 2023 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 03, 2022 Filed May 5, 2022 21:24 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011688 · form4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,178 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 21:59 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 2,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042200 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,183 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2021, December 10, 2021, March 10, 2022 and June 10, 2022 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:59 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001204081-21-000001 · edgar.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,370 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| February 11, 2021 Filed Feb 11, 2021 18:31 UTC | VIRTUSA CORP VRTU · Entity 138065 | Disposition to issuerCommon Stock | 4,773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-009839 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of September 9, 2020 (the "Merger Agreement"), by and among Austin HoldCo Inc., Austin BidCo Inc. ("Sub"), and the Issuer, pursuant to which Sub merged with and into the Issuer (the "Merger") effective as of February 11, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding share of common stock of the Issuer and each unvested restricted stock unit held by the reporting person was cancelled and converted into the right to receive $51.35 in cash without interest and net of any withholding of taxes thereon. F2 · shares: Includes 4,773 unvested restricted stock units. F1 · price: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of September 9, 2020 (the "Merger Agreement"), by and among Austin HoldCo Inc., Austin BidCo Inc. ("Sub"), and the Issuer, pursuant to which Sub merged with and into the Issuer (the "Merger") effective as of February 11, 2021 (the "Effective Time"). At the Effective Time, each issued and outstanding share of common stock of the Issuer and each unvested restricted stock unit held by the reporting person was cancelled and converted into the right to receive $51.35 in cash without interest and net of any withholding of taxes thereon. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 17:46 UTC | VIRTUSA CORP VRTU · Entity 138065 | GrantCommon Stock | 1,989 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064465 · doc4.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,773 F2 · shares: The reporting person was granted shares of restricted stock units on December 16, 2020 under the Company's Fifth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan. The restricted stock units vest over a three-year period at a rate of 33.333% on each of 10/1/21, 10/1/22 and 10/1/23. The award is subject to forward vesting by 12 months upon a change in control of the Company. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 17:46 UTC | VIRTUSA CORP VRTU · Entity 138065 | GrantCommon Stock | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-064465 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,784 F1 · shares: The reporting person was granted shares of restricted stock units on December 16, 2020 under the Company's Fifth Amended and Restated Director Compensation Policy and 2015 Stock Option and Incentive Plan. The restricted stock units vest over a three-year period at a rate of 33.333% on each of 9/1/21, 9/1/22 and 9/1/23. The award is subject to forward vesting by 12 months upon a change in control of the Company. Read SEC document |
| June 11, 2020 Filed Jun 13, 2020 00:16 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 1,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036466 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,050 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2020, December 10, 2020, March 10, 2021 and June 10, 2021 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 05, 2020 Filed May 7, 2020 20:18 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001204081-20-000001 · edgar.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,080 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Read SEC document |
| August 29, 2019 Filed Sep 4, 2019 01:32 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 13.371 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000183 · wf-form4_156756075935160.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,361.719 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:19 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-037536 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,312 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2019, December 10, 2019, March 10, 2020 and June 10, 2020 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 22:23 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 15.53 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000136 · wf-form4_155960059337223.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,348.348 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 07, 2019 Filed May 9, 2019 20:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001204081-19-000007 · edgar.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,856 F1 · shares: The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:40 UTC | SPLUNK INC SPLK · Entity 92815 | SaleCommon Stock | 5,000 | $134.44 | $672,200.00 |
DisclosureSEC source: 0001209191-19-017383 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 20, 2018. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 01:27 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 17.818 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000086 · wf-form4_155174923013973.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,332.818 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 18, 2019 Filed Feb 20, 2019 21:40 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001204081-19-000006 · edgar.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444 F1 · shares: The reporting person received a grant of 444 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. F1 · price: The reporting person received a grant of 444 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 21:34 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000018 · wf-form4_154905685855910.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,315 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 22:02 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 10.286 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000258 · wf-form4_154447930583660.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,406.734 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 31, 2018 Filed Sep 5, 2018 20:35 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 2,719 | $52.45 | $142,611.55 |
DisclosureSEC source: 0000721371-18-000082 · wf-form4_153617974246629.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,725 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 6,059 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 23:01 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 9.004 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000180 · wf-form4_153610209487541.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,396.448 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 15, 2018 Filed Aug 16, 2018 20:48 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 1,534 | $50.17 | $76,960.78 |
DisclosureSEC source: 0000721371-18-000061 · wf-form4_153445247790736.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,444 F1 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,133 restricted share units. F2 · price: Reflects closing price on prior business day. Read SEC document |
| June 07, 2018 Filed Jun 9, 2018 00:14 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 2,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036817 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,359 F1 · shares: The reported shares are represented by restricted stock units ("RSUs"). Twenty-five percent of the RSUs vest on each of September 10, 2018, December 10, 2018, March 10, 2019 and June 10, 2019 (or the Issuer's next annual meeting if earlier). Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 22:17 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 9.472 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000127 · wf-form4_152815056698529.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,387.444 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 8.972 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000072 · wf-form4_152028690534874.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,377.972 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 14:06 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 1,179 | $67.34 | $79,393.86 |
DisclosureSEC source: 0000721371-18-000025 · wf-form4_151878996175073.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,978 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 3,804 restricted share units. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 14:06 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 28,532 | $66.30 | $1,891,671.60 |
DisclosureSEC source: 0000721371-18-000025 · wf-form4_151878996175073.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,157 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.01 to $66.79, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 21:15 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 3,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000035 · wf-form4_151760613459597.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,369 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 23:09 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 12.0059 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000274 · wf-form4_151303374980961.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,876.0976 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 22:15 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 12.397 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000195 · wf-form4_150482252455554.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864.0917 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantEmployee Stock Option (right to buy) · Derivative | 29,517 | $0.00 Strike: $66.43 | $0.00 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · derivative · entry 3 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,517 Underlying: Common Shares · 29,517 shares Expires 2027-08-15 F4 · derivative.exercise_date: Stock option vests in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | Tax withholdingCommon Shares | 3,862 | $66.76 | $257,827.12 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · nonDerivative · entry 2 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,689 F2 · kind: Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,922 RSUs and 6,827 performance share units. F3 · price: Reflects closing price on prior business day. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:33 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 6,021 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000096 · wf-form4_150300559238942.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,551 F1 · kind: Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2018. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:26 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 6,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-17-000070 · wf-form4_150231039816895.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,530 F1 · kind: Reflects performance share units that will settle on August 15, 2017. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 22:13 UTC | SPLUNK INC SPLK · Entity 92815 | GrantCommon Stock | 4,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-038979 · doc4.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,179 F1 · kind: The reported shares are represented by restricted stock units which vest in full on the earlier of the day prior to the Issuer's next annual meeting or June 8, 2018. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 21:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 12.7699 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000132 · wf-form4_149695683605510.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,851.6947 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:37 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 13.9248 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000073 · wf-form4_148857701728152.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,838.9248 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 22:18 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000030 · wf-form4_148616031824015.xml · nonDerivative · entry 1 MORRISON PATRICIA · CIK 0001204081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,825 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.